Interferone und natalizumab in der behandlung der multiplen sklerose (MS) [Interferons and natalizumab for multiple sclerosis]
Clar C, Velasco-Garrido M, Gericke C
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Clar C, Velasco-Garrido M, Gericke C. Interferone und natalizumab in der behandlung der multiplen sklerose (MS). [Interferons and natalizumab for multiple sclerosis] Cologne: German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA@ DIMDI). DAHTA077. 2008
German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information, Waisenhausgasse 36-38a, D-50676 Cologne, Germany Email: dahta@dimdi.de